NCT00544128 - Comparison of Epzicom and Truvada for the Initial Once Daily HIV Treatment | Biotech Hunter

Enrollment

109

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

February 29, 2012

Study Completion Date

February 29, 2012

Conditions

HIV Infections

Interventions

DRUG

lamivudine, abacavir , ritonavir, atazanavir

Patients are treated with Epzicom (lamivudine 300mg and abacavir 600mg) combined with ritonavir 100mg boosted atazanavir 300mg

DRUG

emtricitabine, tenofovir, ritonavir, atazanavir

Patients are treated with Truvada (emtricitabine 200mg and tenofovir 300mg) combined with ritonavir 100mg boosted atazanavir 300mg.

Trial Locations (1)

International Medical Center of Japan, Shinjuku